Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 22.8% in the 3rd quarter, according to its most recent 13F filing ...

Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report) by 58.2% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 875,495 ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today provides ...

We asked our writers to share their best AIM-listed stocks to buy in November, featuring a Hidden Winners recommendation!

The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely.

Generated $50.0 million in net revenue from sales of LUMRYZ™ ----2,300 patients on LUMRYZ as of September 30th, including 700 patients that ...

Proceeds expected to support the upcoming planned launches and fund the continued development of Niktimvo and revumenibExpected to fund Syndax ...